Naïve B-cell receptor specific for Streptococcus pneumoniae capsular polysaccharide (BCR-CPS)

Naïve B-cell receptors specific for Streptococcus pneumoniae capsular polysaccharide (CPS) epitopes are surface-bound immunoglobulins (typically IgM and IgD) that mediate the initial recognition of pneumococcal antigens. These receptors are highly specific to the diverse carbohydrate structures of the S. pneumoniae capsule, which comprises over 100 distinct serotypes (Source: PubMed, PMID: 30139813). Recognition of these epitopes by the BCR is the fundamental step in initiating a humoral immune response against the pathogen. In the context of vaccination, these receptors are targeted by purified polysaccharides or polysaccharide-protein conjugates to stimulate the production of opsonizing antibodies (Source: CDC, 'Pneumococcal Vaccination'). While pure polysaccharides act as T-cell independent antigens that directly cross-link BCRs, conjugate vaccines utilize these receptors to internalize the antigen for processing and presentation to T cells, thereby inducing long-term memory (Source: Nature Reviews Immunology, doi:10.1038/nri3421). Therapeutic strategies focusing on these receptors are essential for preventing invasive pneumococcal disease, particularly in vulnerable populations like infants and the elderly (Source: WHO, 'Pneumococcal Disease'). The activation of these receptors leads to the generation of plasma cells that secrete antibodies capable of neutralizing the bacteria through opsonophagocytosis (Source: StatPearls, 'Pneumococcal Vaccine').

Other names

Pneumococcal capsular polysaccharide-specific B-cell receptorAnti-CPS BCRSurface immunoglobulin specific for S. pneumoniae CPSNaïve B-cell receptor for pneumococcal epitopes

Antigen-mediated cross-linking of B-cell receptors (BCRs) on naïve B cells, triggering intracellular signaling cascades that lead to B-cell proliferation and differentiation into antibody-secreting plasma cells.